Caredx Price To Sales Ratio from 2010 to 2024
| CDNA Stock | USD 22.58 0.21 0.94% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 2.30153843 | Current Value 4.25 | Quarterly Volatility 4.4768164 |
Check Caredx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caredx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.8 M, Interest Expense of 3.7 M or Selling General Administrative of 123.8 M, as well as many indicators such as Price To Sales Ratio of 4.25, Dividend Yield of 0.0 or PTB Ratio of 2.59. Caredx financial statements analysis is a perfect complement when working with Caredx Valuation or Volatility modules.
Caredx | Price To Sales Ratio |
Latest Caredx's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Caredx Inc over the last few years. Price to Sales Ratio is figured by comparing Caredx Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Caredx sales, a figure that is much harder to manipulate than other Caredx Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Caredx's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caredx's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 3.87 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Caredx Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 4.97 | |
| Geometric Mean | 3.72 | |
| Coefficient Of Variation | 90.12 | |
| Mean Deviation | 3.27 | |
| Median | 3.26 | |
| Standard Deviation | 4.48 | |
| Sample Variance | 20.04 | |
| Range | 16.4257 | |
| R-Value | 0.29 | |
| Mean Square Error | 19.75 | |
| R-Squared | 0.09 | |
| Significance | 0.29 | |
| Slope | 0.29 | |
| Total Sum of Squares | 280.59 |
Caredx Price To Sales Ratio History
About Caredx Financial Statements
Caredx stakeholders use historical fundamental indicators, such as Caredx's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Caredx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Caredx's assets and liabilities are reflected in the revenues and expenses on Caredx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Caredx Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 2.30 | 4.25 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Caredx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caredx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:Check out the analysis of Caredx Correlation against competitors. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caredx. If investors know Caredx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caredx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 5.952 | Quarterly Revenue Growth 0.234 | Return On Assets (0.07) | Return On Equity (0.43) |
The market value of Caredx Inc is measured differently than its book value, which is the value of Caredx that is recorded on the company's balance sheet. Investors also form their own opinion of Caredx's value that differs from its market value or its book value, called intrinsic value, which is Caredx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caredx's market value can be influenced by many factors that don't directly affect Caredx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caredx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caredx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caredx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.